ALVOTECH ANNOUNCES FDA ACCEPTANCE FOR REVIEW OF BIOLOGICS LICENSE APPLICATION FOR AVT80, EXPANDING PROPOSED BIOSIMILAR PROGRAM FOR ENTYVIO® TO SUBCUTANEOUS PRESENTATIONS

Reuters · 2d ago

Please log in to view news